Stock Events

Stock Events

Telomir Pharmaceuticals (TELO) Q4 2024 Earnings

12NovConfirmed

Q4 2024

-0.2

0.13

0.47

0.8

Details

Expected EPS

-0.2

Actual EPS

-0.2

Surprise EPS

0

Surprise Percent

+0%

Description

Telomir Pharmaceuticals (TELO) has reported earnings of -0.2 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.